Shield Therapeutics (LSE:STX) Days Payable : 416.60 (As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Shield Therapeutics Days Payable?

Shield Therapeutics's average Accounts Payable for the six months ended in Jun. 2023 was £4.76 Mil. Shield Therapeutics's Cost of Goods Sold for the six months ended in Jun. 2023 was £2.09 Mil. Hence, Shield Therapeutics's Days Payable for the six months ended in Jun. 2023 was 416.60.

The historical rank and industry rank for Shield Therapeutics's Days Payable or its related term are showing as below:

LSE:STX' s Days Payable Range Over the Past 10 Years
Min: 203.19 Med: 1011.46 Max: 4932.98
Current: 451.48

During the past 9 years, Shield Therapeutics's highest Days Payable was 4932.98. The lowest was 203.19. And the median was 1011.46.

LSE:STX's Days Payable is ranked better than
92.94% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.23 vs LSE:STX: 451.48

Shield Therapeutics's Days Payable increased from Jun. 2022 (357.95) to Jun. 2023 (416.60). It may suggest that Shield Therapeutics delayed paying its suppliers.

Shield Therapeutics Days Payable Historical Data

The historical data trend for Shield Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shield Therapeutics Days Payable Chart

Shield Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

1,070.35

1,011.46

412.58

317.70

203.19

Shield Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Payable	Get a 7-Day Free Trial													372.10	415.68	357.95	315.09	416.60

Competitive Comparison of Shield Therapeutics's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Shield Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shield Therapeutics's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shield Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Shield Therapeutics's Days Payable falls into.

Shield Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Shield Therapeutics's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (1.311	+	1.439)	/	2 )	/	2.47	*	365
=	1.375					/	2.47	*	365
=	203.19

Shield Therapeutics's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (1.439	+	8.08)	/	2 )	/	2.085	*	365 / 2
=	4.7595					/	2.085	*	365 / 2
=	416.60

Shield Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Shield Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Shield Therapeutics (LSE:STX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shield Therapeutics PLC (LSE:STX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

SHIEF:USA 1JS:Germany

Address

Northern Design Centre, Baltic Business Quarter, Gateshead Quays, Newcastle, GBR, NE8 3DF

Website

https://www.shieldtherapeutics.com

Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments are based on key products including Accrufer/Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available, and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from Feraccru segment.